Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - verapamilhydrochlorid - depottabletter - 240 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

nordic prime aps - verapamilhydrochlorid - depottabletter - 120 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

nordic prime aps - verapamilhydrochlorid - filmovertrukne tabletter - 80 mg

Den Europæiske Union - dansk - EMA (European Medicines Agency)

accord healthcare s.l.u. - abiraterone acetat - prostatiske neoplasmer - endokrine terapi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

advicenne s.a. - potassium citrate monohydrated, potassium hydrogen carbonate - acidosis, renal tubular - mineral supplements - sibnayal is indicated for the treatment of distal renal tubular acidosis (drta) in adults, adolescents and children aged one year and older.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - verapamilhydrochlorid - filmovertrukne tabletter - 120 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

newbury pharmaceuticals ab - lapatinibditosylatmonohydrat - filmovertrukne tabletter - 250 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - verapamilhydrochlorid - depottabletter - 120 mg

Den Europæiske Union - dansk - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - bimatoprost, timolol - glaucoma, open-angle; ocular hypertension - oftalmologiske - reduktion af intraokulært tryk (iop) hos patienter med åbenvinklet glaukom eller okulær hypertension, som ikke er tilstrækkeligt lydhør overfor aktuelle beta-blokkere eller prostaglandinanaloger.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

novartis europharm limited - trametinib - melanom - antineoplastiske midler - melanomatrametinib as monotherapy or in combination with dabrafenib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 og 5. trametinib monotherapy has not demonstrated clinical activity in patients who have progressed on a prior braf inhibitor therapy (see section 5. adjuvant treatment of melanomatrametinib in combination with dabrafenib is indicated for the adjuvant treatment of adult patients with stage iii melanoma with a braf v600 mutation, following complete resection. ikke-småcellet lungekræft (nsclc)trametinib i kombination med dabrafenib er indiceret til behandling af voksne patienter med avanceret ikke-småcellet lungekræft med en braf v600 mutation.